Elevated serum heparanase‐1 levels in patients with pancreatic carcinoma are associated with poor survival

Abstract

Serum HPR1 activity in pancreatic carcinoma patients was found to be significantly elevated, in particular in those with HPR1-positive tumors. Increased serum HPR1 activity was associated with a shorter survival in patients with pancreatic carcinoma patients.